Source: FactSet. Data may be intentionally delayed pursuant to supplier requirements. Puritan Medical's revenue is the ranked 6th among it's top 10 competitors. President Donald Trump holds a medical swab near his nose as he tours Puritan Medical Products, a medical swab manufacturer, Friday, June 5, 2020, in Guilford, Maine. As such, optimism surrounding Gilead's potential COVID-19 treatment remains justifiably high. "It was amazing!," said Diedra Dow, an operator and assistant production coordinator at Puritan. FREE SHIPPING. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. International stock quotes are delayed as per exchange requirements. Where Will Gilead Sciences Be in 5 Years? We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. © 2020 NEWS CENTER Maine. The company shipped its first batch of COVID-19 vaccines to NIAID to begin clinical testing. While the hypothetical benefits of mRNA treatments seem strong, mRNA vaccines haven't been tested on humans yet. The $51.2 million was funded through the CARES Act and will be used to significantly increase production of flock tip swabs to 50 million per month. As such, there's still some uncertainty as to how humans will react to this new mRNA-based treatment. Whereas DNA-based treatments need to access the nucleus of the cell (where DNA is stored), mRNA can be found all across the cell and is much more accessible. Gilead Sciences (NASDAQ:GILD) was the first biotech stock to break news regarding its potential COVID-19 treatment. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. ON SALE. Fundamental company data and analyst estimates provided by FactSet. The first trial, which will involve between 20 to 25 volunteers, will be finished by the end of April, with initial clinical data likely being available sometime in July of August. (AP Photo/Patrick Semansky). Halvorsen told NEWS CENTER Maine the country is in a crisis and helping by making critically needed swabs was the way he could help out. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life.
All rights reserved. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. In reference to the swabs Puritan makes, Trump said at the time, "I shouldn't be telling you this, I use it every other day.". The other company that's made headway on a potential treatment is Moderna (NASDAQ:MRNA). Copyright, Trademark and Patent Information.
Increasing the production of COVID-19 swabs to at least 90 million per month will provide a tremendous boost to testing efforts, helping to reduce the spread of the virus and allowing us to safely reopen communities,” Senator Susan Collins said. NEW. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. In particular, biotech stocks that are developing potential COVID-19 treatments have seen impressive gains over the past couple of weeks. "I actually have a full-time job, they put a sign up in the middle of town looking for help," said Halvorsen. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. 5 Top NASDAQ Medical Device Stocks of 2019 Jocelyn Aspa - December 5th, 2019 With the year almost over, here the Investing News Network profiles the five top NASDAQ medical device stocks of 2019. View real-time stock prices and stock quotes for a full financial overview. Puritan Medical's top 7 competitors are Berkshire, Valutek, Veltek Associates, Micronova Manufacturing, SPE, Contec and Teknipure. BUY MORE, SAVE MORE! GUILFORD, Maine — Puritan Medical Products, a medical supplies manufacturer based in Guilford, has been awarded $51.2 million to expand its COVID-19 flock tip testing swab production. Moderna's approach to developing a treatment is much different from Gilead's. Together they have raised over 1.4M between their estimated 971 employees. Remdesivir is considered to be an antiviral medication, helping the body fight against viral infections such as Ebola, but can be effective in treating other types of viruses as well. Some Puritan employees shared their thoughts and what it was like as he toured the facility and congratulated the workers for their efforts.
With the coronavirus epidemic continuing to spread, financial markets have seen significant declines. Instead of developing or reusing an existing antiviral drug, Moderna has created a new vaccine for COVID-19 from scratch.
Mix, Stir or Transfer medication ingredients. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. This new award was funded from appropriations provided to HHS by the CARES Act.
Notifications can be turned off anytime in the browser settings. Together, these contracts bring Puritan’s total production of flock tip swabs and foam swabs to at least 90 million per month as well as allow the company to hire additional employees. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. On Jan. 31, doctors decided to give a patient diagnosed with COVID-19 a dose of remdesivir on a compassionate use basis, hoping that the drug might improve the patient's condition. Source: Kantar Media, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. See you at the top! Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. “I commend Puritan’s hardworking employees, and I am proud that this manufacturing that is so critical to the health of our nation is happening right here in our great state.”, RELATED: All swabs will be thrown out following Trump visit, Puritan says.
The facility was the main focus of President Donald Trump's visit to Maine in June. GUILFORD, Maine — Puritan Medical Products, a medical supplies manufacturer based in Guilford, has been awarded $51.2 million to expand its COVID-19 flock tip testing swab production.